frameworks was obtained from a national blueprint for a quality framework, other existing frameworks, input from patient organisations and other relevant parties. The frameworks were sent for review to all members of the scientific societies and consequently tested during two peer reviews per speciality. Improvements to the quality framework were made where appropriate and approved at the general assembly. Results: All nine scientific societies created a quality framework. The same design was used for all frameworks: four quality domains (evaluating care, team performance, patient perspective, and professional development) with multiple aspects (e.g. evaluation of patient records, multidisciplinary meetings, measuring patient satisfaction and knowledge sharing). A grading system was developed with five levels, ranging from excellent (being an example to others) to very poor (the necessity to improve the aspect within a maximum of six months). Differences in settings necessitated adaptations to the framework, e.g. for regional laboratories for medical microbiology or private clinics. In addition, the development of the quality frameworks resulted in changes in other parts of the peer review methodology, e.g. the regulations and the format for the peer review report. In addition, a manual for developing a quality framework for peer review was developed. Conclusion: Using a uniform design, relevant frameworks for peer reviews of medical specialists were developed. The combination of joint and individual meetings resulted in learning from one another and consequently applying this knowledge for the participant's own quality framework. These quality frameworks will support uniform decision making on where quality improvement is required from the groups of medical specialists. Objectives: Regulation is a system level policy used to improve healthcare quality. However, regulation is criticised as ineffective and reactive. In response, regulatory agencies are increasingly concerned with the assessment of improvement capability. Assessing improvement capability is important because organisations with more improvement capability may be more adept to deal with problems and bring about improvement for themselves, while those with limited improvement capability may need more external support and intervention. However, little is known about regulatory perspectives of improvement capability and there are few valid and reliable assessment instruments. Therefore, this study aims to understand how improvement capability is conceptualised and assessed by six national healthcare regulatory agencies across the four countries of the UK. Methods: Hospital care was the study focus as this accounts for the majority of UK healthcare expenditure and a comparative qualitative study was conducted. All six UK healthcare organisational regulatory agencies participated in the study. Three data sources from each agency were used, including regulatory policy documents (n = 90), interviews from a cross-section of regulatory staff (n = 48), and assessment reports (n = 30) during the period 2013-2015. Content and thematic analysis was used to robustly analyse the data using an a priori coding framework. The framework was inductively developed from a comprehensive literature review of 70 instruments used for the assessment of improvement capability and consisted of eight dimensions. They were: Organisational culture; Leadership commitment; Employee commitment; Service user focus; Stakeholder and supplier focus; Process improvement and learning; Strategy and governance; and Data and performance. Manchester Business School ethics process was followed and approval granted.
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Results: The study finds that regulatory agencies want to assess improvement capability accurately, to support the development of more effective system level interventions to ensure improved healthcare quality. The analysis shows that the dimensions of process improvement and learning and strategy and governance were most frequently used. Other dimensions were found less frequently with service-user focus being the least frequent, and this skewed pattern was consistent across agencies. Three themes emerge from the empirical data. First, it is problematic to define and operationalise improvement capability. Policy document and interviews stress the importance of developing improvement capability but do not articulate consistently what is meant by improvement capability. Second, assessments rely on out-of-date and infrequently measured data. Third, there is variable understanding of improvement capability, leading to variation and assessment bias through self-confessed knowledge gaps.
Conclusion:
The study set out to consider how regulatory agencies assess improvement capability. The analysis shows that whilst agencies aim to assess improvement capability, two dimensions are used more frequently than others. This may be due to the difficulty in operationalising improvement capability dimensions, due to measurement, knowledge and practice gaps. The study highlights the need for regulatory agencies to further conceptualise improvement capability to inform assessment and development. This will strengthen agencies assessment, diagnosis and prediction of performance trajectories and support the development of tailored regulatory interventions. 
